Thermo Fisher Scientific Inc said on Friday it completed its 725 million euros ($879.72 million) acquisition of Belgium-based Henogen SA that will help strengthen the medical device maker's position in the fast-growing field of gene therapy manufacturing.

Medical device maker Thermo Fisher Scientific Inc said on Friday it has completed acquisition of Henogen SA, a Belgium-based viral vector manufacturing business, for about 725 million euros ($879.72 million) in cash.

Healthcare services provider Accolade Inc said on Thursday it would buy telehealth startup 2nd.MD for about $460 million to double its addressable market and tap into growing demand for virtual services.

Medical equipment maker Steris Plc is buying rival Cantel Medical Corp for about $3.6 billion to expand into dental care and add endoscopy equipment to its products, it said on Tuesday.

Medical equipment maker Steris Plc said on Tuesday it would buy rival Cantel Medical Corp for about $3.6 billion in a cash-and-stock deal.

Brazilian healthcare company Hapvida SA would remain interested in acquiring "high quality assets" after a potential tie-up with its rival Notre Dame Intermedica, its CEO Jorge Pinheiro told analysts on Monday.

Insurer and hospital operator Hapvida on Friday offered to buy rival Notre Dame Intermedica for 49 billion reais ($9.04 billion) in an all-share deal that would create the country's largest hospital chain.

Health insurer UnitedHealth Group on Wednesday agreed to buy Change Healthcare for $7.84 billion in an all-cash deal, as it looks to expand its fast-growing healthcare technology business.

U.S. drug wholesaler AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business for $6.5 billion to expand in Europe as well as to compete better in the U.S. healthcare sector.

Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.